Ruikang Pharmaceuticals: Net profit in 2025 was 16,071.2 million yuan, a year-on-year increase of 30.73%.

Rui Kang Pharmaceuticals announced that its operating income in 2025 was 7.296 billion yuan, a year-on-year decrease of 8.42%. Net profit was 160.712 million yuan, a year-on-year increase of 30.73%. The profit distribution plan approved by the board of directors is to distribute cash dividends of 0.02 yuan for every 10 shares to all shareholders based on the existing share capital of 1.505 billion shares excluding the shares held by the repurchase special account, and no stock dividends will be issued or capital reserves will be converted into share capital.